Trial intelligence / Profile preview

Treatment of Geriatric Bipolar Mood Disorders: A Pilot Study

NCT00177567Phase 4Completed

Sponsor
University of Pittsburgh
Start
Jul 2001
Modality
DNA Intercalators/Alkylators
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of lithium carbonate, divalproex sodium, risperidone, olanzapine, paroxetine and 5 more in bipolar disorder (BD), sponsored by University of Pittsburgh. Primary endpoints: Percent of subjects remitting from index affective episode, Time to remission and 1 more. Started Jul 2001; status: completed.

02

Drugs

lithium carbonatedivalproex sodiumrisperidoneolanzapineparoxetine
03

Conditions

bipolar disorder (BD)

Beyond the preview

Go deeper on NCT00177567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00177567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call